Cancer
|
Number of lives potentially extended
|
p-value
c
|
---|
1996–2000
|
2004–2008
| |
---|
Number of excess deaths
|
Lives potentially extendedb
|
Proportion of excess deaths (%)
|
Number of excess deaths
|
Lives potentially extendedb
|
Proportion of excess deaths (%)
|
---|
Stomach
|
1967
|
316
|
16.1
|
1895
|
324
|
17.1
|
0.389
|
Colorectum
|
6069
|
443
|
7.3
|
6189
|
606
|
9.8
|
<0.001
|
Liver
|
739
|
137
|
18.6
|
1312
|
312
|
23.8
|
0.006
|
Lung
|
9729
|
1090
|
11.2
|
11,002
|
1779
|
16.2
|
<0.001
|
Melanoma
|
941
|
0a
|
0
|
1213
|
0a
|
0
| |
Breast
|
2188
|
393
|
17.9
|
1855
|
472
|
25.5
|
<0.001
|
Cervix
|
388
|
0a
|
0
|
318
|
92
|
28.9
|
<0.001
|
Uterus
|
356
|
0a
|
0
|
474
|
256
|
54.0
|
<0.001
|
Ovary
|
970
|
0a
|
0
|
1051
|
0a
|
0
| |
Prostate
|
2073
|
311
|
15.0
|
1275
|
411
|
32.3
|
<0.001
|
All of the above
|
25,420
|
2690
|
10.6
|
26,583
|
4253
|
16.0
|
<0.001
|
- aRER coefficients are not significant in the relative survival model for specific cancer
- bEstimated by equating the RER of death due to cancer in the four more disadvantaged SES quintiles to that of the least disadvantaged quintile and calculating the difference in number of cancer deaths
- cPearson chi-square test of the difference between proportions of excess deaths over time (two periods)